Dementia

Dementia

Are biomarkers for Alzheimer’s disease ready for clinical practice? 2:25
Are biomarkers for Alzheimer’s disease ready for clinical practice?
Giancarlo Logroscino • 22 Oct 2020
Debating controversies in ALS 2:54
Debating controversies in ALS
Ettore Beghi • 27 Oct 2020
COVID-19: managing neurodegenerative diseases in southern Italy 6:13
COVID-19: managing neurodegenerative diseases in southern Italy
Giancarlo Logroscino • 22 Oct 2020
Defining Alzheimer’s disease: clinical or biological 2:22
Defining Alzheimer’s disease: clinical or biological
Bart De Strooper • 19 Oct 2020
Cross neurodegenerative disease genetic analysis: similarities and differences 2:20
Cross neurodegenerative disease genetic analysis: similarities and differences
John Hardy • 20 Oct 2020
The reconstructed cohort design: tracking rare neurodegenerative diseases 4:40
The reconstructed cohort design: tracking rare neurodegenerative diseases
Giancarlo Logroscino • 22 Oct 2020
Hopeful developments for Alzheimer’s Disease 1:21
Hopeful developments for Alzheimer’s Disease
Bart De Strooper • 19 Oct 2020
The benefits of GWAS in understanding Alzheimer’s disease 2:00
The benefits of GWAS in understanding Alzheimer’s disease
John Hardy • 20 Oct 2020
Therapeutic development in Alzheimer’s disease and the lack of funding 2:02
Therapeutic development in Alzheimer’s disease and the lack of funding
Bart De Strooper • 19 Oct 2020
The potential of biomarkers in dementia 3:08
The potential of biomarkers in dementia
Giancarlo Logroscino • 22 Oct 2020
Identifying new therapeutic targets for neurodegenerative diseases 1:34
Identifying new therapeutic targets for neurodegenerative diseases
Bart De Strooper • 19 Oct 2020
Cycad toxins driving the ALS-Parkinsonism-Dementia complex 2:40
Cycad toxins driving the ALS-Parkinsonism-Dementia complex
Peter Spencer • 19 Oct 2020
Cognitive impairment in Parkinson’s disease & white matter hyperintensities 2:40
Cognitive impairment in Parkinson’s disease & white matter hyperintensities
Kathleen Poston • 8 Sep 2020
The power of biomarkers: movement disorders 7:35
The power of biomarkers: movement disorders
James Rowe • 7 Sep 2020
The under-representation of females in research: impact in drug development 1:53
The under-representation of females in research: impact in drug development
Christina Dalla • 15 Jul 2020
The importance of sex differences in neuroscience 1:20
The importance of sex differences in neuroscience
Christina Dalla • 15 Jul 2020
The content of VJNeurology is intended for healthcare professionals